Olivares-Hernández, A.; Figuero-Pérez, L.; Terán-Brage, E.; López-Gutiérrez, Á.; Velasco, Á.T.; Sarmiento, R.G.; Cruz-Hernández, J.J.; Miramontes-González, J.P.
Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies. J. Clin. Med. 2021, 10, 1919.
https://doi.org/10.3390/jcm10091919
AMA Style
Olivares-Hernández A, Figuero-Pérez L, Terán-Brage E, López-Gutiérrez Á, Velasco ÁT, Sarmiento RG, Cruz-Hernández JJ, Miramontes-González JP.
Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies. Journal of Clinical Medicine. 2021; 10(9):1919.
https://doi.org/10.3390/jcm10091919
Chicago/Turabian Style
Olivares-Hernández, Alejandro, Luis Figuero-Pérez, Eduardo Terán-Brage, Álvaro López-Gutiérrez, Álvaro Tamayo Velasco, Rogelio González Sarmiento, Juan Jesús Cruz-Hernández, and José Pablo Miramontes-González.
2021. "Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies" Journal of Clinical Medicine 10, no. 9: 1919.
https://doi.org/10.3390/jcm10091919
APA Style
Olivares-Hernández, A., Figuero-Pérez, L., Terán-Brage, E., López-Gutiérrez, Á., Velasco, Á. T., Sarmiento, R. G., Cruz-Hernández, J. J., & Miramontes-González, J. P.
(2021). Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies. Journal of Clinical Medicine, 10(9), 1919.
https://doi.org/10.3390/jcm10091919
